349 related articles for article (PubMed ID: 20528237)
21. Basal Cell Carcinoma in Gorlin's Patients: a Matter of Fibroblasts-Led Protumoral Microenvironment?
Gache Y; Brellier F; Rouanet S; Al-Qaraghuli S; Goncalves-Maia M; Burty-Valin E; Barnay S; Scarzello S; Ruat M; Sevenet N; Avril MF; Magnaldo T
PLoS One; 2015; 10(12):e0145369. PubMed ID: 26694869
[TBL] [Abstract][Full Text] [Related]
22. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle.
Hutchin ME; Kariapper MS; Grachtchouk M; Wang A; Wei L; Cummings D; Liu J; Michael LE; Glick A; Dlugosz AA
Genes Dev; 2005 Jan; 19(2):214-23. PubMed ID: 15625189
[TBL] [Abstract][Full Text] [Related]
23. [Basal cell carcinoma. Molecular genetics and unusual clinical features].
Reifenberger J
Hautarzt; 2007 May; 58(5):406-11. PubMed ID: 17440702
[TBL] [Abstract][Full Text] [Related]
24. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis.
Wong SY; Seol AD; So PL; Ermilov AN; Bichakjian CK; Epstein EH; Dlugosz AA; Reiter JF
Nat Med; 2009 Sep; 15(9):1055-61. PubMed ID: 19701205
[TBL] [Abstract][Full Text] [Related]
25. [The gene of Gorlin's syndrome (basocellular nevomatosis) and the revival of the developmental genes in human carcinogenesis].
Molès JP
Bull Cancer; 1998 Mar; 85(3):207-8. PubMed ID: 9752308
[TBL] [Abstract][Full Text] [Related]
26. Expression of sonic hedgehog signal transducers, patched and smoothened, in human basal cell carcinoma.
Tojo M; Mori T; Kiyosawa H; Honma Y; Tanno Y; Kanazawa KY; Yokoya S; Kaneko F; Wanaka A
Pathol Int; 1999 Aug; 49(8):687-94. PubMed ID: 10504535
[TBL] [Abstract][Full Text] [Related]
27. Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor.
Skvara H; Kalthoff F; Meingassner JG; Wolff-Winiski B; Aschauer H; Kelleher JF; Wu X; Pan S; Mickel L; Schuster C; Stary G; Jalili A; David OJ; Emotte C; Antunes AM; Rose K; Decker J; Carlson I; Gardner H; Stuetz A; Bertolino AP; Stingl G; De Rie MA
J Invest Dermatol; 2011 Aug; 131(8):1735-44. PubMed ID: 21430703
[TBL] [Abstract][Full Text] [Related]
28. Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway.
Svärd J; Heby-Henricson K; Persson-Lek M; Rozell B; Lauth M; Bergström A; Ericson J; Toftgård R; Teglund S
Dev Cell; 2006 Feb; 10(2):187-97. PubMed ID: 16459298
[TBL] [Abstract][Full Text] [Related]
29. Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.
Bakshi A; Chaudhary SC; Rana M; Elmets CA; Athar M
Mol Carcinog; 2017 Dec; 56(12):2543-2557. PubMed ID: 28574612
[TBL] [Abstract][Full Text] [Related]
30. Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies.
Ruiz Salas V; Alegre M; Garcés JR; Puig L
Expert Rev Anticancer Ther; 2014 Jun; 14(6):741-9. PubMed ID: 24611655
[TBL] [Abstract][Full Text] [Related]
31. Activating Smoothened mutations in sporadic basal-cell carcinoma.
Xie J; Murone M; Luoh SM; Ryan A; Gu Q; Zhang C; Bonifas JM; Lam CW; Hynes M; Goddard A; Rosenthal A; Epstein EH; de Sauvage FJ
Nature; 1998 Jan; 391(6662):90-2. PubMed ID: 9422511
[TBL] [Abstract][Full Text] [Related]
32. Molecular conversations and the development of the hair follicle and basal cell carcinoma.
Harris PJ; Takebe N; Ivy SP
Cancer Prev Res (Phila); 2010 Oct; 3(10):1217-21. PubMed ID: 20858758
[TBL] [Abstract][Full Text] [Related]
33. Basal cell carcinoma: pathophysiology.
Sehgal VN; Chatterjee K; Pandhi D; Khurana A
Skinmed; 2014; 12(3):176-81. PubMed ID: 25134314
[TBL] [Abstract][Full Text] [Related]
34. Sox9 Controls Self-Renewal of Oncogene Targeted Cells and Links Tumor Initiation and Invasion.
Larsimont JC; Youssef KK; Sánchez-Danés A; Sukumaran V; Defrance M; Delatte B; Liagre M; Baatsen P; Marine JC; Lippens S; Guerin C; Del Marmol V; Vanderwinden JM; Fuks F; Blanpain C
Cell Stem Cell; 2015 Jul; 17(1):60-73. PubMed ID: 26095047
[TBL] [Abstract][Full Text] [Related]
35. AKT1 Activation is Obligatory for Spontaneous BCC Tumor Growth in a Murine Model that Mimics Some Features of Basal Cell Nevus Syndrome.
Kim AL; Back JH; Zhu Y; Tang X; Yardley NP; Kim KJ; Athar M; Bickers DR
Cancer Prev Res (Phila); 2016 Oct; 9(10):794-802. PubMed ID: 27388747
[TBL] [Abstract][Full Text] [Related]
36. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.
Sharpe HJ; Pau G; Dijkgraaf GJ; Basset-Seguin N; Modrusan Z; Januario T; Tsui V; Durham AB; Dlugosz AA; Haverty PM; Bourgon R; Tang JY; Sarin KY; Dirix L; Fisher DC; Rudin CM; Sofen H; Migden MR; Yauch RL; de Sauvage FJ
Cancer Cell; 2015 Mar; 27(3):327-41. PubMed ID: 25759019
[TBL] [Abstract][Full Text] [Related]
37. Hair cycle-dependent basal cell carcinoma tumorigenesis in Ptc1neo67/+ mice exposed to radiation.
Mancuso M; Leonardi S; Tanori M; Pasquali E; Pierdomenico M; Rebessi S; Di Majo V; Covelli V; Pazzaglia S; Saran A
Cancer Res; 2006 Jul; 66(13):6606-14. PubMed ID: 16818633
[TBL] [Abstract][Full Text] [Related]
38. Targeting the hedgehog pathway to treat basal cell carcinoma.
Geeraert P; Williams JS; Brownell I
J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
[TBL] [Abstract][Full Text] [Related]
39. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
Reifenberger J; Wolter M; Knobbe CB; Köhler B; Schönicke A; Scharwächter C; Kumar K; Blaschke B; Ruzicka T; Reifenberger G
Br J Dermatol; 2005 Jan; 152(1):43-51. PubMed ID: 15656799
[TBL] [Abstract][Full Text] [Related]
40. The hedgehog pathway and basal cell carcinomas.
Bale AE; Yu KP
Hum Mol Genet; 2001 Apr; 10(7):757-62. PubMed ID: 11257109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
